Investing Profile

Vikas Goyal

Photo of Vikas Goyal, Principal at SR One
Your Intro Paths to Vikas Goyal

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Vikas is a member of
Harvard University Network
252 CONNECTIONS
McKinsey & Company Network
138 CONNECTIONS
University of Pennsylvania Network
135 CONNECTIONS
The Wharton School Network
107 CONNECTIONS

Find Vikas Goyal on

cb
Current Investing Position
SR One Principal
Investments On Record
8

Vikas Goyal's Investments On Record (4)

CompanyStageDateRound SizeTotal Raised
Pandion Therapeutics
Series AJan 2018$58M
$140M
Co-investors: Alan Crane (Polaris Partners), Carlo Rizzuto (Versant Ventures), Dan Becker (Access Biotechnology)
Spero Therapeutics
Series CMar 2017$52M
Series BFeb 2016$30M
Series AJun 2015$30M
$120M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Reza Halse (RA Capital), Jean-François Formela (Atlas Venture), Michael Gladstone (Atlas Venture)
Morphic Therapeutic
Series AJun 2016$52M
$140M
Co-investors: Kevin Bitterman (Atlas Venture), Timothy A. Springer
CalciMedica
Series CDec 2009$12M
Series CJan 2009$4M
Series AJul 2007$2M
$18M

Vikas Goyal's Experience

Associate SR One2011 - Present
Manager, Corporate Strategy & Development Infinity Pharmaceuticals2010 - 2011
Intern SR One2009 - 2010
Co-Chair TiE Social Entrepreneurs2006 - 2008
Senior Associate, Co-Founder Extera Partners2004 - 2008
Associate, PureTech Development PureTech Ventures2004 - 2007
Senior Analyst McKinsey & Company2001 - 2003

Vikas Goyal's Education

The Wharton School MBA Business
University of Pennsylvania MBA Health Care Management
Harvard University BA Neurobiology